Nothing Special   »   [go: up one dir, main page]

SG11201706734SA - Mixed allergen compositions and methods for using the same - Google Patents

Mixed allergen compositions and methods for using the same

Info

Publication number
SG11201706734SA
SG11201706734SA SG11201706734SA SG11201706734SA SG11201706734SA SG 11201706734S A SG11201706734S A SG 11201706734SA SG 11201706734S A SG11201706734S A SG 11201706734SA SG 11201706734S A SG11201706734S A SG 11201706734SA SG 11201706734S A SG11201706734S A SG 11201706734SA
Authority
SG
Singapore
Prior art keywords
methods
same
mixed allergen
allergen compositions
compositions
Prior art date
Application number
SG11201706734SA
Inventor
Kari C Nadeau
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56689334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201706734S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of SG11201706734SA publication Critical patent/SG11201706734SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201706734SA 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same SG11201706734SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562119014P 2015-02-20 2015-02-20
PCT/US2016/018731 WO2016134291A2 (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same

Publications (1)

Publication Number Publication Date
SG11201706734SA true SG11201706734SA (en) 2017-09-28

Family

ID=56689334

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201706734SA SG11201706734SA (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same
SG10201909093X SG10201909093XA (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201909093X SG10201909093XA (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same

Country Status (22)

Country Link
US (4) US10064936B2 (en)
EP (2) EP4186521A1 (en)
JP (3) JP6859261B2 (en)
KR (2) KR20170117562A (en)
CN (2) CN114129720A (en)
AU (2) AU2016219793C1 (en)
CA (1) CA2977127A1 (en)
DK (1) DK3258962T3 (en)
ES (1) ES2937287T3 (en)
FI (1) FI3258962T3 (en)
HK (1) HK1247854A1 (en)
HU (1) HUE061576T2 (en)
IL (1) IL253976B2 (en)
LT (1) LT3258962T (en)
MA (1) MA41558B1 (en)
MX (2) MX2017010697A (en)
PL (1) PL3258962T3 (en)
PT (1) PT3258962T (en)
RS (1) RS63941B1 (en)
SG (2) SG11201706734SA (en)
SI (1) SI3258962T1 (en)
WO (1) WO2016134291A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL253976B2 (en) 2015-02-20 2024-09-01 Univ Leland Stanford Junior Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) * 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160263212A1 (en) * 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
NZ753163A (en) * 2016-11-21 2023-05-26 Nestle Sa Liquid allergen compositions and methods for making the same
US10656145B2 (en) 2016-12-09 2020-05-19 General Mills, Inc. Detection of allergens using surface-enhanced raman scattering
JP2020514306A (en) * 2017-01-13 2020-05-21 アイミューン セラピューティクス，インコーポレイテッド Method for producing nut flour and formulations for oral immunotherapy
FR3062797A1 (en) * 2017-02-10 2018-08-17 Centre Hospitalier Et Universitaire De Clermont-Ferrand GASTROINTESTINAL RELEASE GELULE FOR USE IN A METHOD FOR DESENSITIZING AND / OR INDUCING TOLERANCE IN AN ALLERGIC PEANUT SUBJECT
US20180360951A1 (en) * 2017-06-20 2018-12-20 Evros Vassiliou Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d
IL272033B2 (en) 2017-07-18 2023-09-01 Before Brands Inc Methods for making mixed allergen compositions
US11173113B2 (en) 2017-12-06 2021-11-16 Prollergy Corporation Composition and method for reducing allergic response
EP3836801A4 (en) * 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
EP3886899A1 (en) * 2018-11-30 2021-10-06 Alladapt Immunotherapeutics, Inc. Methods for making mixed allergen compositions
JP2022514642A (en) * 2018-12-21 2022-02-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Infant drinking composition
KR20210130147A (en) 2019-01-23 2021-10-29 비포어 브랜즈, 인크. Method for preparing mixed allergen composition
US20200236982A1 (en) * 2019-01-28 2020-07-30 Lil Mixins, Llc Tree nut powder formulation
US11154082B2 (en) 2019-06-13 2021-10-26 Lil Mixins, Llc Egg product for infants and babies and method of making same
US11324247B2 (en) 2019-06-13 2022-05-10 Lil Mixins, Llc Food products for infants and babies and method of making same
WO2022185284A1 (en) * 2021-03-05 2022-09-09 Société des Produits Nestlé S.A. Methods of making and assessing allergenic tree nut compositions
US11154081B1 (en) 2021-03-16 2021-10-26 Lil Mixins, Llc Well cooked egg powder
US11439173B1 (en) 2021-09-22 2022-09-13 Lil Mixins, Llc Low allergenicity well cooked food powder

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
GB9323483D0 (en) 1993-11-13 1994-01-05 Cerestar Holding Bv Edible composition and a process for its preparation
AU2065801A (en) 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
US6716471B2 (en) 2000-05-12 2004-04-06 Sigmund Kramer Peanut powder compositions and methods of making same
FR2822709B1 (en) 2001-03-30 2007-01-19 Antialis ANTI-ALLERGIC PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE ALLERGEN AND AT LEAST ONE ANTIHISTAMINE COMPOUND
DE602004032025D1 (en) 2003-06-23 2011-05-12 Biotech Tools Sa EPITOPIC COMPOSITION FOR ENTERIAN ADMINISTRATION MADE BY HYDROLYSIS OF ANTIGENIC STRUCTURES WITH CHYMOTRYPSIN
US7595081B1 (en) 2003-10-17 2009-09-29 Bellar Willis F Non-flour containing baked and related food compositions
WO2005077410A1 (en) * 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
EP1993376A1 (en) * 2006-02-27 2008-11-26 The Iams Company Animal food composition comprising nut shell
EP1872792A1 (en) 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
CN101646418B (en) * 2006-10-12 2013-07-17 昆士兰大学 Compositions and methods for modulating immune responses
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US20100278880A1 (en) 2008-01-02 2010-11-04 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
SI2244734T1 (en) 2008-02-01 2016-11-30 Murdoch Childrens Research Institute A method of inducing tolerance to an allergen
EP2140880B1 (en) 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification of allergens
US8802056B2 (en) 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
JP5805363B2 (en) 2009-06-26 2015-11-04 和興フィルタテクノロジー株式会社 Soluble aggregate, immune tolerance inducer and method for producing the same
CN102695427B (en) * 2009-08-18 2016-04-13 雀巢产品技术援助有限公司 Comprise Lactococcus strain and in immunoenzyme technics, particularly reduce the alimentation composition of allergic symptom
BR112012005117A2 (en) * 2009-09-07 2016-05-03 Dbv Tech eosinophilic esophagitis treatment method
CN102048077A (en) * 2009-10-30 2011-05-11 梁振 Convenient and nutritious pudding beancurd jelly
ES2904800T3 (en) 2010-04-30 2022-04-06 Allovate Llc Oral strip for allergic desensitization through the vestibular mucosal surface
EP2563390A4 (en) * 2010-04-30 2014-05-14 Allovate Llc Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
GB201009368D0 (en) 2010-06-04 2010-07-21 Sana Pharma As Dietary formulations
EP2627355B1 (en) 2010-10-15 2015-08-26 ALK-Abelló A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CN102986802A (en) 2012-12-11 2013-03-27 崔杰 Making method of salted peanut and walnut cake
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
CA2903229A1 (en) 2013-03-14 2014-10-02 Aimmune Therapeutics, Inc. Manufacture of peanut formulations for oral desensitization
BR112015024040A2 (en) 2013-03-19 2017-07-18 Biotech Tools Sa allergenic preparation
WO2014195803A2 (en) 2013-06-06 2014-12-11 Anergis S.A. Contiguous overlapping peptides for treatment of house dust mites allergy
KR102385900B1 (en) * 2013-09-19 2022-04-11 알로베이트, 엘엘씨 Toothpaste for delivering allergens to oral mucosa
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
KR102541110B1 (en) 2014-08-25 2023-06-08 에이뮨 테라퓨틱스, 인코퍼레이티드 Egg protein formulations and methods of manufacture thereof
CN104273238A (en) * 2014-09-27 2015-01-14 合肥市凤落河豆制食品有限公司 Sesame sauced dried bean curd and preparation method thereof
US10166286B2 (en) * 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) * 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) * 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
IL253976B2 (en) * 2015-02-20 2024-09-01 Univ Leland Stanford Junior Mixed allergen compositions and methods for using the same
US20160263212A1 (en) 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens

Also Published As

Publication number Publication date
KR20170117562A (en) 2017-10-23
EP3258962A2 (en) 2017-12-27
JP6859261B2 (en) 2021-04-14
AU2022201699A1 (en) 2022-04-07
SI3258962T1 (en) 2023-07-31
JP2021046445A (en) 2021-03-25
MX2017010697A (en) 2017-11-17
PL3258962T3 (en) 2023-04-24
AU2016219793B2 (en) 2021-12-16
HK1247854A1 (en) 2018-10-05
IL253976A0 (en) 2017-10-31
US20170056494A1 (en) 2017-03-02
LT3258962T (en) 2023-02-27
US20220133882A1 (en) 2022-05-05
HUE061576T2 (en) 2023-07-28
EP3258962A4 (en) 2018-07-11
JP2022125346A (en) 2022-08-26
CN107405394A (en) 2017-11-28
BR112017017894A2 (en) 2018-04-10
IL253976B1 (en) 2024-05-01
US9731003B2 (en) 2017-08-15
US10064936B2 (en) 2018-09-04
FI3258962T3 (en) 2023-04-12
CN107405394B (en) 2021-12-14
WO2016134291A2 (en) 2016-08-25
AU2016219793A1 (en) 2017-08-31
EP4186521A1 (en) 2023-05-31
EP3258962B1 (en) 2022-11-02
JP7509829B2 (en) 2024-07-02
US20190038741A1 (en) 2019-02-07
AU2016219793C1 (en) 2022-03-17
MA41558A (en) 2017-12-26
MX2022008663A (en) 2022-08-10
IL253976B2 (en) 2024-09-01
CN114129720A (en) 2022-03-04
US20160243217A1 (en) 2016-08-25
JP2018505907A (en) 2018-03-01
CA2977127A1 (en) 2016-08-25
ES2937287T3 (en) 2023-03-27
KR20240148968A (en) 2024-10-11
RS63941B1 (en) 2023-02-28
WO2016134291A3 (en) 2016-10-13
PT3258962T (en) 2023-02-16
MA41558B1 (en) 2023-02-28
DK3258962T3 (en) 2023-02-06
SG10201909093XA (en) 2019-11-28

Similar Documents

Publication Publication Date Title
HK1247854A1 (en) Mixed allergen compositions and methods for using the same
HK1257295A1 (en) Compositions and methods for immunooncology
HK1253306A1 (en) Anti-ntb-a antibodies and related compositions and methods
GB201513304D0 (en) Compositions and Methods
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
IL246879B (en) Apilimod compositions and methods for using same
HK1245158A1 (en) Apilimod compositions and methods for using same
GB201706355D0 (en) Methods compositions and uses relating thereto
IL266672A (en) Liquid allergen compositions and methods for making the same
HK1247136A1 (en) Compositions comprising 15-hepe and methods of using the same
GB201706352D0 (en) Methods compositions and uses relating thereto
GB201706356D0 (en) Methods compositions and uses relating thereto
GB201715785D0 (en) Methods compositions and uses relating thereto
IL272033B1 (en) Methods for making mixed allergen compositions
GB2550632B (en) Compositions and uses and methods relating thereto
PT3113774T (en) Compositions of grapiprant and methods for using the same
GB201705626D0 (en) Compositions and methods
ZA201807665B (en) Methods and compositions
GB201715820D0 (en) Compositions and methods
GB201512996D0 (en) Compositions and methods
GB201514413D0 (en) Compositions and methods
ZA201807782B (en) Methods and compositions
GB201518167D0 (en) Methods and compositions
GB201514415D0 (en) Compositions and methods